Congratulations to Andrew Frisch, a 3rd year graduate student in the Delgoffe Lab, for receiving an NCI NRSA grant (F31CA257760) entitled "Metabolically Improving the Generation, Function, and Persistence of Therapeutic T Cells for the Treatment of Cancer.